| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives |
| 01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
| 01/29/2004 | US20040019017 Caspase inhibitor prodrugs |
| 01/29/2004 | US20040018543 Incubation; controlling temperature and pH |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383735A1 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1000016B1 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives. |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1470503A Method for preparing N-ethoxy oxalyl-alanine ethyl ester |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/22/2004 | WO2004007430A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | WO2004007429A1 Cinnamide derivatives |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | US20040014975 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction |
| 01/22/2004 | US20040014816 Novel aliphatic compounds, process for their preparation and their usage |
| 01/22/2004 | CA2493372A1 Cinnamide derivatives |
| 01/22/2004 | CA2492046A1 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/21/2004 | EP1382591A1 Novel atisane compound and use thereof |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/21/2004 | EP1381355A2 Matrix metalloproteinase inhibitors |
| 01/21/2004 | EP1257265B1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 01/21/2004 | CN1468847A Closed polyisocyanic acid ester |
| 01/20/2004 | CA2098116C Compositions and method for improving the slip of polyolefins and the adhesion of water based inks to polyolefins |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | US20040010154 Diastereoselective hydrogenation of 1,3-hydroxyketones |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | US20040010028 Self-assembled nanostructures with macroscopic polar order |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/14/2004 | EP1380564A1 Binaphtol derivative and process for producing the same |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1380558A1 Process for production of dimers of aromatic monohydroxyl compounds |
| 01/14/2004 | EP1379257A2 Prodrugs of anticancer agents employing substituted aromatic acids |
| 01/14/2004 | EP1212292B1 (-)-verbenone derivatives |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468210A Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/14/2004 | CN1134383C Nitrification process |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | CA2049162C Ortho-substituted phenylacetamides |
| 01/08/2004 | WO2004003102A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 01/08/2004 | WO2004002947A1 Phenoxypropenylphenyl derivatives and their use as herbicides |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2003076392A3 Z-substituted acrylamides, methods for production thereof and agents comprising the same |
| 01/08/2004 | WO2003030819A3 Tetracycline derivatives and methods of use thereof |
| 01/08/2004 | WO2002044398A3 Universal supports for oligonucleotide synthesis |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040005282 2-(alpha-hydroxy-C20-38-fatty carbonylamino)-3,6-dihydroxy-C16-25-alk-4-enyl C14-20-fatty acid ester; used for strengthening the lipid barrier of the epidermis. |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1378501A1 Diastereoselective hydrogenation of beta-hydroxyketones |
| 01/07/2004 | EP1377551A1 Antiproliferative agents |
| 01/07/2004 | EP1377321A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/06/2004 | US6673788 Containing 2,2,2-trifluoro-1-oxoethyl groups |
| 01/06/2004 | US6673784 Halosubstituted acetophenones as selective herpesvirus protease inhibitors |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/06/2004 | CA2276598C Method for synthesis of rhizoferrin |
| 01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 01/02/2004 | EP1375548A1 Blocked polyisocyanates |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372667A2 Compositions for delivering bisphosphonates |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1372615A1 Compounds and compositions for delivering active agents |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002480 Aminobutyric acid derivatives and pharmaceutical composition containing the same as active ingredient |
| 12/31/2003 | WO2004000790A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 12/31/2003 | WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 12/31/2003 | CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |